Patients will titrate up from a base dose of a GLP-1 RA to an eventual maintenance dose, increasing the dosage after around four weeks at each stop, depending on any adverse effects that may arise
What should I do if I experience side effects during the first week of Semaglutide GLP-1 use
Typical Wegovy-related fatigue is not dangerous, though it can be uncomfortable and disruptive
Sources FDA Import Alert 66-80: Detention Without Physical Examination of Drug Products Containing GLP-1 Receptor Agonists and Certain Peptide Drug Products Federal Food, Drug, and Cosmetic Act Section 801 (Imports) FDA Drug Establishments Current Registration Site (DECRS) FDA: Frequently Asked Questions About Drug Shortages FDA Warning Letters Database PeptideKnow: Supply Chain and Enforcement Are the Real Bottlenecks (Apr 22, 2026) Sources & References FDA PCAC Meeting Announcement (July 23-24, 2026) PBS: FDA to Weigh Easing Limits on Peptides Favored by RFK Jr
Compounding pharmacies operate under state and, in some cases, federal oversight, but practices can vary
